Product NDC: | 60505-0751 |
Proprietary Name: | Ceftriaxone Sodium |
Non Proprietary Name: | Ceftriaxone Sodium |
Active Ingredient(s): | 500 mg/1 & nbsp; Ceftriaxone Sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0751 |
Labeler Name: | Apotex Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065230 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050802 |
Package NDC: | 60505-0751-0 |
Package Description: | 1 VIAL in 1 BOX (60505-0751-0) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 60505-0751-0 |
Proprietary Name | Ceftriaxone Sodium |
Package Description | 1 VIAL in 1 BOX (60505-0751-0) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 60505-0751 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ceftriaxone Sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20050802 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corporation |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |